Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS - Document - Gale Academic OneFile
![PDF) Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial PDF) Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial](https://i1.rgstatic.net/publication/343434086_Simplified_dolutegravir_dosing_for_children_with_HIV_weighing_20_kg_or_more_pharmacokinetic_and_safety_substudies_of_the_multicentre_randomised_ODYSSEY_trial/links/5f47f0de299bf13c5040abf7/largepreview.png)
PDF) Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial
AUSTRALIAN PRODUCT INFORMATION DOVATO (dolutegravir/lamivudine fixed-dose combination) film-coated tablets 1 NAME OF THE MEDICIN
![Dosing Considerations | See Boxed Warning for TRIUMEQ & TRIUMEQ PD (abacavir, dolutegravir, lamivudine) Dosing Considerations | See Boxed Warning for TRIUMEQ & TRIUMEQ PD (abacavir, dolutegravir, lamivudine)](https://i-cf65.gskstatic.com/content/dam/cf-viiv/triumeq-hcp/master/triumeq_pd_chart_desktop_v4.png?auto=format)
Dosing Considerations | See Boxed Warning for TRIUMEQ & TRIUMEQ PD (abacavir, dolutegravir, lamivudine)
![SINGLE AND MULTIPLE DOSE DOLUTEGRAVIR PHARMACOKINETICS IN THE GENITAL TRACT AND COLORECTUM OF HIV NEGATIVE MEN AND WOMEN SINGLE AND MULTIPLE DOSE DOLUTEGRAVIR PHARMACOKINETICS IN THE GENITAL TRACT AND COLORECTUM OF HIV NEGATIVE MEN AND WOMEN](https://www.natap.org/2013/images/040413/040413-3/CROI1.gif)
SINGLE AND MULTIPLE DOSE DOLUTEGRAVIR PHARMACOKINETICS IN THE GENITAL TRACT AND COLORECTUM OF HIV NEGATIVE MEN AND WOMEN
AUSTRALIAN PRODUCT INFORMATION TIVICAY (dolutegravir) film-coated tablets 1 NAME OF THE MEDICINE 2 QUALITATIVE AND QUANTITATIVE
![A single dose of ultra-LA dolutegravir protects against multiple high... | Download Scientific Diagram A single dose of ultra-LA dolutegravir protects against multiple high... | Download Scientific Diagram](https://www.researchgate.net/publication/328147212/figure/fig4/AS:958879806550024@1605626169280/A-single-dose-of-ultra-LA-dolutegravir-protects-against-multiple-high-dose-HIV-1.png)
A single dose of ultra-LA dolutegravir protects against multiple high... | Download Scientific Diagram
![Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial - The Lancet HIV Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial - The Lancet HIV](https://www.thelancet.com/cms/attachment/433edd2b-fff4-445f-b185-84f12030ea5b/gr1_lrg.gif)
Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial - The Lancet HIV
![Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial - The Lancet HIV Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial - The Lancet HIV](https://www.thelancet.com/cms/attachment/4dcbeea0-d1ac-4fc6-9a1d-4e40e9d1d7fa/gr2_lrg.jpg)
Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial - The Lancet HIV
![New approaches for paediatric dosing: abacavir in newborns, doubling dolutegravir with rifampicin | aidsmap New approaches for paediatric dosing: abacavir in newborns, doubling dolutegravir with rifampicin | aidsmap](https://www.aidsmap.com/sites/default/files/styles/aidsmap_medium_crop/public/2020-03/paediatric-dosing-article.png?itok=lZqnGk_u)
New approaches for paediatric dosing: abacavir in newborns, doubling dolutegravir with rifampicin | aidsmap
![Table 5 from Dolutegravir (DTG) Based Fixed Dose Combination (FDC) of Tenofovir/Lamivudine/Dolutegravir (TLD) and Viral Load Suppression in Children in Port Harcourt, Nigeria | Semantic Scholar Table 5 from Dolutegravir (DTG) Based Fixed Dose Combination (FDC) of Tenofovir/Lamivudine/Dolutegravir (TLD) and Viral Load Suppression in Children in Port Harcourt, Nigeria | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cb00916211b891dbe206930c27fcd5421b4559e3/6-Table5-1.png)
Table 5 from Dolutegravir (DTG) Based Fixed Dose Combination (FDC) of Tenofovir/Lamivudine/Dolutegravir (TLD) and Viral Load Suppression in Children in Port Harcourt, Nigeria | Semantic Scholar
![Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial - ScienceDirect Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2352301820301892-gr3.jpg)
Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial - ScienceDirect
![Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial - The Lancet HIV Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial - The Lancet HIV](https://www.thelancet.com/cms/attachment/963a2c61-e97c-498c-b5e1-b8c4695026cf/gr1_lrg.jpg)